The number of clinical trial registries that drug companies and
researchers can use if they want to have their results later
published in prominent medical journals has been increased.
Meanwhile, as of July next year, Phase I trials...
Phase 0 studies have a great potential in selecting drug candidates
early in the drug development but the pharma industry will stay
sceptical until more research has been done, said Prof. Colin
Garner, CEO of microdosing service firm...
Veeda Clinical Research, an Anglo-Indian contract research
organisation (CRO) formed two years ago, said it will soon enter
the US market with a new acquisition - the fourth since the
US-based contract research organisation (CRO) Covance is offering
microdosing studies for early clinical development without the
perceived drawbacks of having to radiolabel compounds for detection
through ultra-sensitive accelerator...